Prostaglandin coverage and costs to medicare and medicare beneficiaries, 2009-2017

Medicine & Life Sciences

• Bimatoprost 100%
• Latanoprost 90%
• Medicare 77%
• Prostaglandins 70%
• Synthetic Prostaglandins 68%
• Health Expenditures 63%
• Travoprost 60%
• Prescription Drugs 58%
• Costs and Cost Analysis 46%
• Formularies 33%
• tafluprost 22%
• Medicare Part D 19%
• Generic Drugs 17%
• Drug Costs 15%
• Glaucoma 11%
• Prescriptions 10%

Chemical Compounds

• Prostaglandin 85%
• Bimatoprost 71%
• Latanoprost 69%
• Prescription Drug 50%
• Travoprost 45%
• Tafluprost 16%
• Generic Drug 13%

Social Sciences

• coverage 56%
• medication 45%
• costs 42%
• drug 36%
• pricing 10%